Chemotherapy induced Takotsubo cardiomyopathy

作     者：Sunny Goel Abhishek Sharma Aakash Garg Abhinav Chandra Vijay Shetty 

作者机构：Department of Medicine Maimonides Medical Center Department of Internal Medicine James J. Peters VA Medical Center Mount Sinai School of Medicine Bronx NY 10468 United States 

出 版 物：《World Journal of Clinical Cases》 (世界临床病例杂志)

年 卷 期：2014年第2卷第10期

页      面：565-568页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Takotsubo cardiomyopathy Chemotherapy Cytarabine Daunorubicin 

摘      要：Chemotherapy has been linked with Takotsubo cardiomyopathy. Most of the literature on chemotherapy associated Takotsubo cardiomyopathy is on the drug 5-fluorouracil. In this report, we describe the case of a 55-year-old Asian male who developed Takotsubo cardiomyopathy while receiving dual chemotherapy with cytarabine and daunorubicin for acute myeloid leukemia. To our knowledge, it is the first case of Takotsubo cardiomyopathy associated with daunorubicin and/or cytarabine.